Her2-negative breast carcinoma Clinical Trials

Delta Trials catalogs 23 clinical trials for Her2-negative breast carcinoma in its publicly accessible dataset. Within this set, 15 currently recruiting participants and 0 trials have reached completion. This research occurs across 959 participating sites around the world. An additional 8 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 1 trial were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.